Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma

Detalles Bibliográficos
Autores principales: Xie, Qian, Zheng, Hanrui, Chen, Ye, Peng, Xingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360972/
https://www.ncbi.nlm.nih.gov/pubmed/35958843
http://dx.doi.org/10.3389/fpubh.2022.965798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360972/
https://www.ncbi.nlm.nih.gov/pubmed/35958843
http://dx.doi.org/10.3389/fpubh.2022.965798

Ejemplares similares